Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
A pan-SARS-CoV-2 specific soluble ACE2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery
Monitoring recommendations: Baseline investigations: Full blood count, B12 level, folate, and intrinsic factor antibodies (if pernicious anaemia suspected) During initial treatment: Potassium monitoring in severe deficiency (risk of hypokalaemia) Follow-up: Repeat full blood count after 8 weeks to confirm haematological response Long-term: Annual review to ensure compliance with maintenance injections
Provided in sealed containers, this material is suitable for professional research environments that rely on standardized workflows and accurate record keeping
Strict standards guide BAC water use within clinical environments
The intranasal administration(inhalation route, i.n route) of vaccines may achieve a better protection effect on preventing SARS-CoV-2 infection (especially Omicron variant)
No, these medications don't cause low blood sugar (hypoglycemia) by themselves
